Alkahest

Alkahest is a clinical-stage biopharmaceutical company primarily focused on neurodegenerative and age-related diseases. Their transformative therapies are derived from a deep understanding of the plasma proteome in aging and disease. They are developing clinical candidates that can increase or decrease levels of key circulating timing factors to promote innate and natural restorative biological processes or inhibit pathological degenerative processes. Their therapies include both traditional drug treatments and highly screened and refined plasma components, as well as other methods for antagonizing or supplementing the most biologically active timing factors.